Suscribirse

Experimental study of tendon healing early phase: Is IGF-1 expression influenced by platelet rich plasma gel? - 07/06/10

Doi : 10.1016/j.otsr.2010.03.010 
D.N. Lyras a, , K. Kazakos a, G. Agrogiannis b, D. Verettas a, A. Kokka b, G. Kiziridis a, E. Chronopoulos c, M. Tryfonidis a
a Democritus University Hospital of Thrace, Department of Orthopaedic and Trauma Surgery, Alexandroupolis, 84100 Dragana, Greece 
b National and Kapodistrian University of Athens, Greece, 1st Department of Pathology, School of Medicine, 75, Mikras Asias street, 11527, Greece 
c Konstantopoulion University Hospital, Nea Ionia, Athens, Greece 

Corresponding author. Argyrokastrou 31B, 15235 Vrilissia, Athens, Greece. Tel.: +30 6949313155.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Summary

Background

It is well established that growth factors play a critical role in the healing process of connective tissues. To our knowledge, there are no studies in literature concerning the influence of PRP on growth factors expression.

Hypothesis

The aim of this study was to assess the effect of a single application of platelet rich plasma (PRP) gel in a patellar tendon defect on the spatial and temporal expression of Insulin-like Growth Factor 1 (IGF-1) during tendon healing.

Materials and methods

Twenty-four animals were randomized to receive PRP (PRPFast, Bioteck) in a gel form (PRP group) and 24 to serve as untreated controls (Control group). A defect of 3mm×10mm was surgically created on the tendon under general anaesthetic and in the PRP group, PRP gel was applied to fill the tendon defect whereas no treatment was applied in the control group. Six animals (12 limbs) from each treatment-group were sacrificed after one, two, three and four weeks following treatment. Histological and immunohistochemical staining were performed.

Results

Histology revealed a faster healing process in the tendons of PRP group in comparison with the controls. In the first 2 weeks of healing, IGF-1 was found intracellularly in various type cells, whereas in the last 2 weeks of healing, IGF-1 was detected mainly in tenocytes. Both cytoplasmic and nuclear expressions were present, whereas the larger amounts of immunoexpression were localized in both epitenon and endotenon. A superior expression of IGF-1 was seen in PRP group compared with controls (p<0.0001) in both the epitenon and endotenon at each time point except at 4th week of healing where a superior expression of IGF-1 was shown in the endotenon of control group, compared to the PRP group (p<0.0001).

Conclusion

PRP may improve tendon defect healing by overexpression of IGF-1.

Level of evidence

Laboratory control animal study.

El texto completo de este artículo está disponible en PDF.

Keywords : Platelet rich plasma, Tendon healing, Immunohistochemistry, Growth factors, IGF-1


Esquema


© 2010  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 96 - N° 4

P. 381-387 - juin 2010 Regresar al número
Artículo precedente Artículo precedente
  • Does hyperflex total knee design improve postoperative active flexion?
  • P. Massin, F.-R. Dupuy, H. Khlifi, C. Fornasieri, T. De Polignac, P. Schifrine, C. Farenq, P. Mertl
| Artículo siguiente Artículo siguiente
  • Does reconstruction of isolated chronic posterior cruciate ligament injuries restore normal knee function?
  • A. Wajsfisz, P. Christel, P. Djian

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.